Published • loading... • Updated
Campaigners question ethics of puberty-blocker trial in legal letter to Streeting
Campaigners argue the trial risks irreversible harm to vulnerable children and lacks ethical and legal justification despite regulators' approvals and planned safeguards.
- Campaigners have questioned the ethics of a puberty-blocker trial for children in a legal letter to Wes Streeting, the shadow health secretary.
- Keira Bell, who was given puberty blockers as a teenager and regrets it, said children could be harmed from the trial and their fertility and sexual function affected.
- The Department of Health said the trial will help provide evidence currently lacking, and its approval came after rigorous safety checks with safeguards to protect young people's wellbeing.
Insights by Ground AI
25 Articles
25 Articles
Legal Challenge Targets UK National Health Service Puberty Blocker Trial
Campaigners have launched a legal action aimed at suspending a new NHS-funded trial of puberty blockers, claiming the research could harm participating children. The Pathways trial, run by King’s College London, plans to recruit about 226 children aged 10 to 15 over three years. The trial was commissioned following last year’s Cass review, which found gender medicine for minors relied on weak evidence. Participants will either receive puberty bl…
Coverage Details
Total News Sources25
Leaning Left5Leaning Right4Center9Last UpdatedBias Distribution50% Center
Bias Distribution
- 50% of the sources are Center
50% Center
L 28%
C 50%
R 22%
Factuality
To view factuality data please Upgrade to Premium

















